US Senator Elizabeth Warren increased pressure on regulators to scrutinize CVS Health Corp.’s $9.5 billion deal to buy Oak Street Health Inc., as part of a broad critique of vertical consolidation in the industry that she says could increase costs and reduce quality.
The Federal Trade Commission should not only review the CVS acquisition for impacts on competition and care quality, but also revisit previous transactions in the sector, the Massachusetts Democrat said in a letter addressed to commissioners on March 17 that was provided by her office.
